Close

VIVUS Reports Topline Findings From FORTRESS Dec 21, 2011 04:00PM
VIVUS (VVUS) Reports Publication of Encouraging Qnexa Data in Cardiometabolic Disease Patients Dec 8, 2011 08:09AM
SEQUEL Trial Results for Qnexa® Published in AJCN Show 10% Sustained Weight Loss Over 2 Years Dec 8, 2011 08:00AM
Weight Loss and Effects on Diabetes with Qnexa Treatment Results Presented at the World Diabetes Congress Dec 7, 2011 06:45AM
Qnexa® Phase 3 Data Published In Obesity Show 14.4% Average Weight Loss In Severely Obese Patients Completing One Year Of Treatment Nov 3, 2011 05:00PM


Nov 3, 2011 12:15PM FDA Accepts New Drug Application Filing for Qnexa
Oct 3, 2011 08:56AM VIVUS (VVUS) Presents Three Posters for Qnexa; Highlights Improvement in Liver Function
Jul 29, 2011 03:22PM Trader Radar for 08/01: Humana (HUM), Sohu (SOHU), Changyou (CYOU) Report; Constructio Spending, ISM Due
May 31, 2011 11:07AM VIVUS (VVUS) Presents Additional Positive QNEXA Data at ECO
Feb 28, 2011 05:50PM After-Hours Movers 02/28: (SONS) (NVAX) (LMAT) (EXLS) Higher; (RXII) (ARCI) (HTCO) Lower
Aug 2, 2010 03:43PM Trading Radar for 08/03: Dow Chemical (DOW), CBS Corp. (CBS), MasterCard (MA), MGM Resorts (MGM) Report
Jun 8, 2010 07:29AM VIVUS (VVUS) Reports 'Statistically Significant' Data for OSA Treatment Qnexa
Jan 6, 2010 05:02PM VIVUS (VVUS) To Announce Qnexa Phase 2 Results January 7, 2009
Dec 29, 2009 07:08AM VIVUS (VVUS) Submits NDA to U.S. FDA for Qnexa Obesity Treatment
Sep 18, 2009 08:26AM Arena Pharmaceuticals (ARNA) Falls As Results Fall Short Against Others